Ed Kong

MD/PhD student in economics @HarvardEcon, @harvardMed, and @HarvardMITmdphd. Originally @Yale BME/Econ. Researching health care markets.

[Leemore Dafny @LeemoreDafny]

Should the federal government force insurers and PBMs to divest medical service providers in order to prevent the rise of health care prices and spending? This JAMA Viewpoint shares my thoughts on this policy idea. https://t.co/lnsI7B5CQG @Kennedy_School @HarvardHBS @HBSHealth

[Crémieux @cremieuxrecueil]

Eli Lilly has done it.

They've gone and made what seems to be a powerful, permanent gene therapy for LDL cholesterol.

That means they'll be able to effectively prevent most heart disease with a single infusion!

[Ed Kong @edkong]

What a wonderful conference! Honored to have had the opportunity to present along with such impressive researchers @ruochen_s @NTilipman @andrewolenski @zayetz A huge thanks to all of the organizers!

[Laura Wherry @LaurawherryR]

The day is finally here! It’s NYC Health Econ Day! 🎉 Looking forward to spending the day hearing about incredible research and catching up with local colleagues. See you all soon! Cc: @MJ_Dickstein @sunitamd @jnvanparys @amy_m_bond

[BIDMC Smith Center @SmithBIDMC]

🎉 Congrats to Josh Angrist, Visiting Professor and Bobby Yeh, Director at the Smith Center and coauthors Peter Hull and Carol Gao on being awarded The Willard G. Manning Memorial Award for the Best Research in Health Econometrics from @ashecon. 🔗https://t.co/7sN9n5XVhJ

[Ed Kong @edkong]

Just one of many reasons I’m excited to be starting my prelim medicine internship at BIDMC!

[BIDMC Smith Center @SmithBIDMC]

🎉 Congrats to Josh Angrist, Visiting Professor and Bobby Yeh, Director at the Smith Center and coauthors Peter Hull and Carol Gao on being awarded The Willard G. Manning Memorial Award for the Best Research in Health Econometrics from @ashecon. 🔗https://t.co/7sN9n5XVhJ

[Ed Kong @edkong]

I'm honored to have worked on this project with my wonderful mentors and co-authors Ryan Sullivan, Hensin Tsao, and @DrStevenTChen.

[Ed Kong @edkong]

I’m excited to share a new paper in JAAD on novel therapies in melanoma 🧵

We show melanoma mortality fell by ~26% following the introduction of immunotherapy and targeted therapies. https://t.co/bDARjSOIlH

[Ed Kong @edkong]

These findings suggest that while novel therapies have transformed melanoma outcomes, a meaningful share of their potential benefit remains unrealized, particularly outside larger counties. Further work is needed to maximize the benefits of important new treatments.

[Healio Dermatology @HealioDerm]

💻A simulation model in @JAMADerm shows the greatest QOL gains are linked with biologic therapies for #psoriasis.

💡Home phototherapy offers ⬇️ cost for patients & payers, yet remains underused.

@GoHealio spoke with @edkong of @harvardmed to learn more.
https://t.co/Sz8pC1VLrA

[Parker Rogers @parker_rog]

🚨 What happens when the gov't cuts prices on medical technologies?

New research (w/ @YunanJi) finds a 61% price cut led to:

75% drop in innovation (may fully offset savings)
49% fewer new firms
28% more production moved overseas
3x repair/replacement rate

🧵(1/n)

[Ed Kong @edkong]

Truly an honor to have had the chance to write this paper with @AMostaghimi

[JAMA Dermatology @JAMADerm]

Specialty medications, particularly new biologics, contributed to the rise in dermatology drug spending under #Medicare Part D from 2013 to 2022, primarily due to increased prescribing. https://t.co/wgQJadYPYw @edkong

[Peter Hull @instrumenthull]

Not too much goin' on today, so I thought I'd tell you about a new paper just published in @NEJMEvidence, w/ @metrics52, @carolxmgao, and @rwyeh

We explain why instrumental variable (IV) methods are essential for randomized trials of medical interventions that fail to play out as intended (i.e., with imperfect treatment takeup & control group crossover)

In an application to the landmark ISCHEMIA trial, these methods show that the benefits of revascularization on quality of life are 46% higher than what a conventional "intentions-based" analysis would suggest

Check it out! https://t.co/0Aw9gVQbBA

[Ed Kong @edkong]

What a time to be alive